Results for erysipelas translation from English to Slovenian

erysipelas
erizipel

swine erysipelas,
rdečica,

wound infection, erysipelas,
okužba rane, erizipel,

swine erysipelas vaccine (inactivated)
cepivo proti svinjski rdečici (inaktivirano)

this will help protect them against swine erysipelas.
to bo pripomoglo k zaščiti prašičev pred svinjsko rdečico.

for swine erysipelas two laboratory studies were conducted.
za svinjsko rdečico sta bili izvedeni dve laboratorijski študiji.

porcine parvovirosis and swine erysipelas vaccine (inactivated)
cepivo proti prašičji parvovirozi in svinjski rdečici (inaktivirano)

this will help protect them against porcine parvovirus and swine erysipelas.
to bo pripomoglo k zaščiti prašičev pred prašičjo parvovirozo in svinjsko rdečico.

to stimulate active immunisation against porcine parvovirus and swine erysipelas.
za stimulacijo aktivne imunizacije proti prašičjemu parvovirusu in rdečici.

however, the duration of immunity of the erysipelas component following mixed use has not been investigated.
trajanje imunosti komponente rdečice pri uporabi mešanega cepiva ni raziskana.

helicobacter infection, herpes zoster, erysipelas, wound infection, gingival infection, labrynthitis, bacterial infection
okužba s helicobactrom, herpes

eryseng is used to protect male and female pigs against swine erysipelas caused by erysipelothrix rhusiopathiae bacteria of specific types called serotype 1 and serotype 2.
zdravilo eryseng se uporablja za zaščito prašičjih samcev in samic pred svinjsko rdečico, ki jo povzroča bakterija erysipelothrix rhusiopathiae posebnih vrst, imenovanih serotip 1 in serotip 2.

in absssi, the types of infections treated were confined to cellulitis/erysipelas or major cutaneous abscesses, and wound infections only.
pri akutnih bakterijskih okužbah kože in mehkih tkiv so bile zdravljene vrste okužb omejene samo na celulitis/šen ali večje kožne abscese in okužbe ran.

for mixed use the onset and duration of immunity of the parvovirus component and the onset of immunity of the erysipelas component have been demonstrated to be equivalent to those determined for eryseng parvo when used alone.
dokazali so, da so pri uporabi mešanice cepiv nastop in trajanje imunosti pri komponenti rdečice in nastop imunosti pri parvovirusni komponentienaki , kot če uporabimo samo cepivo eryseng parvo.

for the active immunisation of male and female pigs to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by erysipelothrix rhusiopathiae, serotype 1 and serotype 2.
za aktivno imunizacijo merjascev in plemenskih svinj za zmanjšanje kliničnih znakov (kožnih lezij in vročine) rdečice, ki jo povzroča bakterija erysipelothrix rhusiopathiae, serotip 1 in serotip 2.

the referral deals with the issue that in the opinion of france equivalence between the reference vaccine batch for the erysipelas batch potency test validated in the original dossier and the new reference vaccine batches was not shown for these 2 batches and that consequently the cvmp needed to consider whether to vary, withdraw or suspend the marketing authorisation.
napotitveni postopek obravnava vprašanje enakovrednosti, ki po mnenju francije med referenčno serijo cepiva za preskus učinkovitosti serije proti erizipelu, ki je bila potrjena v prvotni dokumentaciji, in med novimi referenčnimi serijami cepiva ni bila izkazana za ti dve seriji, zato je posledično cvmp moral razmisliti o spremembi, umiku ali preklicu dovoljenja za promet z zdravilom.

during assessment of a type ii variation for changing the mouse potency test to comply with the revised ph. eur monograph for erysipelas vaccines, vaccine batch 8500 was accepted as being a reference vaccine and therefore this batch and those prior to it have to be accepted as being compliant with the conditions of the marketing authorisations for both products.
med ocenjevanjem variacije tipa ii za spremembo testa farmakološke učinkovitosti pri miših, da bi ta ustrezal popravljeni monografiji evropske farmakopeje (ph. eur) za cepiva proti erizipelu, je bila kot referenčno cepivo sprejeta serija cepiva 8500, zaradi česar je treba to serijo in tiste pred njo sprejeti kot skladne s pogoji dovoljenja za promet z zdravilom za oba izdelka.

7 skin lesions induced by cetuximab may predispose patients to superinfections (e. g. with s. aureus), which may lead to subsequent complications, e. g. cellulitis, erysipelas, or, potentially with fatal outcome, staphylococcal scalded skin syndrome or sepsis.
7 kombinirano zdravljenje